Smoking

Global PDGFR Inhibitors Market (2021 to 2026) - Featuring AstraZeneca, Bayer and Eli Lilly Among Others - ResearchAndMarkets.com

Friday, October 22, 2021 - 4:30pm

Avapritinib sold under brand name Ayvakit is the first approved PDGFR inhibitor available in market.

Key Points: 
  • Avapritinib sold under brand name Ayvakit is the first approved PDGFR inhibitor available in market.
  • The drug was developed by Blueprint Medicines and is mainly indicated for the treatment of gastrointestinal tumors (GIST) and mastocytosis.
  • Although the market is poised to growth in coming years but several factors limits their growth in market.
  • This will increase the demand of targeted therapies, thus driving the growth of PDGFR inhibitor market.

Broadway Vascular Announces Top-Line Results of 12-Month Retrospective Analysis Evaluating Revascularization of the Lateral Plantar Artery in Diabetic Neuropathy

Friday, October 22, 2021 - 3:00pm

SAN ANTONIO, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular today announced top-line data from a retrospective analysis of Dr. Broadway's revolutionary revascularization technique, involving treating of the lateral plantar artery for treatment of diabetic neuropathy.

Key Points: 
  • SAN ANTONIO, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Broadway Vascular today announced top-line data from a retrospective analysis of Dr. Broadway's revolutionary revascularization technique, involving treating of the lateral plantar artery for treatment of diabetic neuropathy.
  • Dr. Broadway hypothesized that revascularization of the lateral plantar artery will result in regrowth of the nerve fibers, restoring sensation, therefore, treating diabetic neuropathy.
  • The intervention included revascularization of the lateral plantar artery using an atherectomy device with balloon angioplasty.
  • This retrospective study suggests the potential value of revascularization of the lateral plantar artery for treating diabetic neuropathy.

Global Antibody Drug Conjugates Market Research Report 2021: COVID-19 Growth and Change to 2025 & 2030 - ResearchAndMarkets.com

Friday, October 22, 2021 - 12:13pm

The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The challenges involved in the manufacturing of ADC's is acting as a restraint on the antibody drug conjugates market.
  • Global Antibody Drug Conjugates Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
    6.2.
  • Global Antibody Drug Conjugates Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

FEELM Issues Press Statement on FDA’s First Vaping Product Authorization

Friday, October 22, 2021 - 7:03am

It is the first set of ENDS products authorized by the FDA through the Premarket Tobacco Product Application (PMTA), marking a milestone for the global vaping regulations.

Key Points: 
  • It is the first set of ENDS products authorized by the FDA through the Premarket Tobacco Product Application (PMTA), marking a milestone for the global vaping regulations.
  • The scientific data submitted by R.J.Reynolds Vapor has demonstrated the health benefits of Vuse tobacco-flavored ENDS.
  • In September 2020, the company has completed the PMTA submissions of Vuse Alto, which is powered by FEELM ceramic coil.
  • The authorization of Vuse Solo by FDA is a sign of more authorizations of ENDS products to come.

CDC Awards ICF $35 Million in Public Health Contracts

Thursday, October 21, 2021 - 9:05pm

"ICF has partnered with CDC programs for over 30 years, and we have the right people and the right skills in place to meet their complex needsfrom public health research to data analytics and IT modernization to communications and citizen engagement," said Mark Lee, ICF executive vice president and public sector lead.

Key Points: 
  • "ICF has partnered with CDC programs for over 30 years, and we have the right people and the right skills in place to meet their complex needsfrom public health research to data analytics and IT modernization to communications and citizen engagement," said Mark Lee, ICF executive vice president and public sector lead.
  • "We look forward to continuing to help CDC advance the critical public health missions of its programs."
  • ICF brings together a broad set of public health, health technology and technical support services to help organizations solve their most complex challenges.
  • Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future.

Canadian Vaping Association: 100 experts in nicotine science and policy challenge the WHO to change its stance on vaping

Thursday, October 21, 2021 - 7:38pm

Often restrictions to vape products are justified as cautious policy, with health agencies citing uncertainty in vapings long term health consequences.

Key Points: 
  • Often restrictions to vape products are justified as cautious policy, with health agencies citing uncertainty in vapings long term health consequences.
  • We believe that it is time for global tobacco policy to draw on the full potential of tobacco harm reduction.
  • Many of the worlds most credible experts are speaking out at the highest levels to advocate that vaping remains accessible to adult smokers.
  • The experts and the science have been clear that if properly supported vaping could prevent the premature death of millions of people globally, said Darryl Tempest, Executive Director of the CVA.

Insights on the Abdominal Aortic Aneurysm Treatment Global Market to 2027 - Growing Demand of Novel Treatments Presents Opportunities - ResearchAndMarkets.com

Thursday, October 21, 2021 - 4:19pm

The Global Abdominal Aortic Aneurysm Treatment Market report provides a holistic evaluation of the market for the forecast period.

Key Points: 
  • The Global Abdominal Aortic Aneurysm Treatment Market report provides a holistic evaluation of the market for the forecast period.
  • The Global Abdominal Aortic Aneurysm Treatment Market study provides an outlook on the development of market in terms of revenue throughout the prognosis period.
  • This report provides an all-inclusive environment of the analysis for the Global Abdominal Aortic Aneurysm Treatment Market.
  • The report also focuses on the competitive landscape of the Global Abdominal Aortic Aneurysm Treatment Market.

22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results

Wednesday, October 20, 2021 - 2:20pm

(Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science, will host a live webcast on Thursday, November 4, 2021, at 10:00 AM ET to discuss its 2021 third quarter results.

Key Points: 
  • (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science, will host a live webcast on Thursday, November 4, 2021, at 10:00 AM ET to discuss its 2021 third quarter results.
  • 22nd Century will report the Companys third quarter 2021 results in a press release at 6:00 AM ET the same day.
  • During the webcast, James A. Mish, chief executive officer; Michael Zercher, chief operating officer; and John Franzino, chief financial officer, will review third quarter results and discuss progress made in each of the Companys three franchises.
  • 22nd Century Group, Inc. (Nasdaq: XXII ) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science.

Global High Potency Active Pharmaceutical Ingredients Market to 2028 - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Wednesday, October 20, 2021 - 1:16pm

The "High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house, Outsourced), By Drug Type, By Application, By Region, And Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house, Outsourced), By Drug Type, By Application, By Region, And Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global high potency active pharmaceutical ingredients market size is expected to reach USD 38.84 billion by 2028, according to a new report by the publisher It is expected to expand at a CAGR of 8.4% from 2021 to 2028.
  • The market is driven by an increased focus on targeted therapies and a surge in demand for cancer therapies.
  • The rising prevalence of cancer is a major factor expected to drive the market for high potency active pharmaceutical ingredients (HPAPIs).

Global Traditional Wound Management Market Size, Share & Trends Analysis Report 2021 - ResearchAndMarkets.com

Tuesday, October 19, 2021 - 5:31pm

The "Global Traditional Wound Management Market Size, Share & Trends Analysis Report by Product (Gauze, Tapes, Cotton), by Application, by End-use (Hospitals, Clinics, Home Healthcare), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Traditional Wound Management Market Size, Share & Trends Analysis Report by Product (Gauze, Tapes, Cotton), by Application, by End-use (Hospitals, Clinics, Home Healthcare), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global traditional wound management market size is expected to reach USD 7.7 billion by 2028 and is expected to expand at a CAGR of 3.7% from 2021 to 2028.
  • The rising incidence of chronic diseases, increasing number of accidents, and rising number of ambulatory surgery centers (ASCs) are the key driving factors for the market.
  • Chapter 3 Traditional Wound Management Market Variables, Trends & Scope